Wed, Jan 03, 2024
Sun Pharma hits a new high after acquiring Israel's Libra Merger, consolidating its presence in the region. This follows a recent US investment in Lyndra Therapeutics. We break down the deals and their potential impact on Sun Pharma's future.
More >
Fri, Dec 22, 2023
Pharma shares gave returns ranging from 15% to 90%... Nifty Pharma reached record level. Nifty Pharma: What are the triggers of the rise? See here...
Mon, Dec 11, 2023
Reddy's Laboratories Ltd (DRREDDY) shares plunged after the drug maker received three observations from the US drug maker for its Bachupally facility in Hyderabad.
Fri, Nov 24, 2023
Lupin shares rose on Friday after the US drug regulator cleared two of the Mumbai-based pharmaceutical company's products.
Mon, Nov 20, 2023
The FDA classified the findings of the inspection as 'no action indicated', which which means no objectionable conditions or practices were found during the inspection.
Fri, Sep 29, 2023
Aurobindo Pharma surged on Friday, trading in huge volumes, after sources told Zee Business that the company received approval to launch its Revlimid drug.
Wed, Sep 27, 2023
The FMCG and Pharma sectors outperformed, with investors adopting a defensive approach to navigate global challenges, said Vinod Nair, Head of Research at Geojit Financial Services.
Thu, Sep 21, 2023
Cipla shares remained under pressure on Thursday after the US drug regulator issued five observations about a New York-based facility of the company's wholly-owned subsidiary, InvaGen Pharmaceuticals.
Tue, Sep 12, 2023
Lupin shares surged to a 52-week high on Tuesday, surpassing a peak touched last week, after the drug maker's board announced a business transfer agreement worth Rs 750-850 crore with its subsidiary, Lupin Manufacturing Solutions.
Fri, Aug 11, 2023
Aurobindo Pharma is likely to report a 12.7 per cent year-on-year jump in consolidated net profit to Rs 586 crore for the quarter ended June 30, according to Zee Business research.
Divi's Labs is likely to report a 42.6 per cent year-on-year fall in consolidated net profit to Rs 403 crore for the quarter ended June 30, according to Zee Business research.
Fri, Jul 28, 2023
Dr Reddy's Laboratories (DRL) shares have scaled a series of record peaks in the past few days. This week, the pharmaceutical major reported a strong all-round quarterly performance, with a better-than-expected 18.2 per cent year-on-year increase in net profit to Rs 1,405 crore for the April-June period.
Tue, Jul 25, 2023
Dr Reddy's Labs is scheduled to report its financial results for the June quarter on July 26. Analysts expect DRLto stage a strong quarterly performance driven by growing demand and improving margin.
Thu, Jul 20, 2023
Favorite shares of market experts, Which stocks did veteran investors buy? In which stocks did veterans increase their stake?
Dr Reddy's Labs shares scaled a 52-week high on Thursday after the drug maker said the US regulator completed an inspection at its Srikakulam API facility without any observation.
Wed, Jun 07, 2023
Zee Business brings to you 3 pharma stocks recommended by brokerage firms to keep an eye out for.
Wed, May 31, 2023
Torrent Pharma shares surged to a 52-week high on Wednesday, a day after the drug maker reported a quarterly net profit as against a net loss for the corresponding period a year ago.
Tue, May 30, 2023
AstraZeneca Pharma dividend: AstraZeneca Pharma India's board on Tuesday announced a dividend of Rs 16 per equity share for the financial year 2022-23.
Fri, May 19, 2023
Gland Pharma share price NSE, Gland Pharma share price target: Gland Pharma shares plunged on Friday 20, a day after the Hyderabad-based generic injectable manufacturer reported a weak set of financial results for the quarter ended March 2023.
Tue, May 16, 2023
Granules India Q4 results, dividend news: Granules India — a Hyderabad-based pharma company that makes Paracetamol and Ibuprofen — reported a net profit of Rs 119.6 crore for the quarter ended March 2023, missing analysts' estimates. Granules India's board recommended a dividend of 150 per cent.
Mon, May 15, 2023
Granules India Q4 results preview: Granules India, which manufactures painkiller drug Paracetamol and anti-inflammatory drug Ibuprofen, will report its Q4 results on May 16. Will Granules India also announce a dividend?
Mon, Apr 24, 2023
Why are Sun Pharma shares under pressure today? Sun Pharma declined due to which news? How much will be the impact on Sun Pharma? Know the complete details from Nupur in this video.
Tue, Mar 28, 2023
Pharma stocks were a mixed bag on Tuesday, as Sun Pharma, Lupin, Biocon, Aurobindo Pharma, Pfizer, Granules and Glaxosmith succumbed to selling pressure, and Cipla, Natco Pharma, Glenmark, Dr Reddy, Abbott India and Ipca Labs managed to eke out gains. Drug pricing regulator NPPA fixed retail prices of 25 formulations.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
